<main class="news-article" lang="en" role="main">
      
<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    News story
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    Publication of the ACMD report into the availability and use of naloxone
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
      <p class="gem-c-lead-paragraph">The Advisory Council on the Misuse of Drugs (ACMD) has published a report reviewing the availability and use of naloxone in the UK, a drug used to reverse opioid overdose.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/advisory-council-on-the-misuse-of-drugs">Advisory Council on the Misuse of Drugs</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">17 June 2022</dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>






<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds ">
    <div class="content-bottom-margin">
      <div class="responsive-bottom-margin">
        <figure class="app-c-figure" lang="en">
    <img alt="" class="app-c-figure__image" src="https://assets.publishing.service.gov.uk/media/5e59279b86650c53b2cefbfe/placeholder.jpg">
  <figcaption class="app-c-figure__figcaption">
  </figcaption>
</figure>

        
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
          <div class="govspeak">
<p>The Advisory Council on the Misuse of Drugs (ACMD) has published a report reviewing the availability and use of naloxone in the UK, a drug used to reverse opioid overdose.</p>

<p>The advice follows a self-commission by ACMD members in 2019 after a small rise in opioid overdose-related deaths.</p>

<p>The report outlines evidence that administration of naloxone leads to a reduction in these types of deaths, however it also concluded that more work is needed to increase the availability and use of this drug.</p>

<p>The report has made the following recommendations to government:</p>

<ol>
  <li>
    <p>Improve the quality of data on take-home naloxone and ensure local authority commissioners monitor how it is provided by service providers.</p>
  </li>
  <li>
    <p>Further research should be undertaken to see how those at risk of overdose can more easily access take-home naloxone.</p>
  </li>
  <li>
    <p>Good examples of partnership working cited in the report should be used to model naloxone programmes across the UK.</p>
  </li>
  <li>
    <p>Prison services should ensure people being released from prison who are at high-risk of overdosing have access to take-home naloxone.</p>
  </li>
  <li>
    <p>Additional training for police in the holding and administration of naloxone should be provided and police services should register to gain required exemptions to supply take-home naloxone.</p>
  </li>
  <li>
    <p>Hospitals, mental health trusts and ambulance services should deliver take-home naloxone and training to those at risk of overdose. Guidance should be updated to include appropriate recommendations on naloxone provision.</p>
  </li>
  <li>
    <p>There should be arrangements across the UK which allow community pharmacies to deliver take-home naloxone and intervention on managing opioid overdoses.</p>
  </li>
</ol>

<p>The ACMD has previously reviewed the use and availability of naloxone in 2012 and recommended it to be made more widely available.</p>

<p>In 2015 the government introduced changes to the Human Medicines Amendment Regulations (2012) which expanded the availability of naloxone in the UK, but this report hopes to encourage a further increase in naloxone availability and use.</p>

<p>ACMD chair Professor Owen Bowden-Jones said:</p>

<blockquote>
  <p>We are pleased to share today our findings on take-home naloxone. Naloxone is a life-saving medication and it is crucial that it is easily available to people at risk. Only a national, cross-sector approach will achieve this.</p>

  <p class="last-child">We look forward to the Government response to this report and our findings.</p>
</blockquote>

<p>Read the <a class="govuk-link" href="https://www.gov.uk/government/publications/acmd-naloxone-review">ACMD naloxone review</a>.</p>
</div>

</div>
      </div>

      <div class="dont-print responsive-bottom-margin">
          <div class="gem-c-share-links govuk-!-display-none-print" data-module="gem-track-click">
      <h2 class="gem-c-share-links__title">Share this page</h2>

    <ul class="gem-c-share-links__list">
        <li class="gem-c-share-links__list-item">
          <a class="govuk-link govuk-link--no-underline gem-c-share-links__link " data-track-action="facebook" data-track-category="social media" data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;facebook&quot;,&quot;socialTarget&quot;:&quot;https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fpublication-of-the-acmd-report-into-the-availability-and-use-of-naloxone&quot;}" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fpublication-of-the-acmd-report-into-the-availability-and-use-of-naloxone" rel="noopener noreferrer external" target="_blank">
            <span class="gem-c-share-links__link-icon">
                <svg focusable="false" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                  <path d="M24 12.073c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.99 4.388 10.954 10.125 11.854v-8.385H7.078v-3.47h3.047V9.43c0-3.007 1.792-4.669 4.533-4.669 1.312 0 2.686.235 2.686.235v2.953H15.83c-1.491 0-1.956.925-1.956 1.874v2.25h3.328l-.532 3.47h-2.796v8.385C19.612 23.027 24 18.062 24 12.073z" fill="currentColor"></path>
                </svg>
            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Facebook
</a>
        </li>
        <li class="gem-c-share-links__list-item">
          <a class="govuk-link govuk-link--no-underline gem-c-share-links__link " data-track-action="twitter" data-track-category="social media" data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;twitter&quot;,&quot;socialTarget&quot;:&quot;https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fpublication-of-the-acmd-report-into-the-availability-and-use-of-naloxone\u0026text=Publication%20of%20the%20ACMD%20report%20into%20the%20availability%20and%20use%20of%20naloxone&quot;}" href="https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fpublication-of-the-acmd-report-into-the-availability-and-use-of-naloxone&amp;text=Publication%20of%20the%20ACMD%20report%20into%20the%20availability%20and%20use%20of%20naloxone" rel="noopener noreferrer external" target="_blank">
            <span class="gem-c-share-links__link-icon">
                <svg focusable="false" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                  <path d="M23.953 4.57a10 10 0 01-2.825.775 4.958 4.958 0 002.163-2.723c-.951.555-2.005.959-3.127 1.184a4.92 4.92 0 00-8.384 4.482C7.69 8.095 4.067 6.13 1.64 3.162a4.822 4.822 0 00-.666 2.475c0 1.71.87 3.213 2.188 4.096a4.904 4.904 0 01-2.228-.616v.06a4.923 4.923 0 003.946 4.827 4.996 4.996 0 01-2.212.085 4.936 4.936 0 004.604 3.417 9.867 9.867 0 01-6.102 2.105c-.39 0-.779-.023-1.17-.067a13.995 13.995 0 007.557 2.209c9.053 0 13.998-7.496 13.998-13.985 0-.21 0-.42-.015-.63A9.935 9.935 0 0024 4.59z" fill="currentColor"></path>
                </svg>
            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Twitter
</a>
        </li>
    </ul>
</div>
      </div>

      <div class="app-c-published-dates" lang="en">
    Published 17 June 2022
</div>

    </div>
  </div>

  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/health-and-social-care" data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Health and social care&quot;}" href="/health-and-social-care">Health and social care</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>